Blincyto
Blincyto : Uses, Side effects, and Interactions
The generic name for Blincyto is blinatumomab. This pharmaceutical agent is classified as a CD19 monoclonal antibody.
Treatment of Acute lymphoblastic leukemia
The side effects of Blincyto include: